You just read:

Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval Process

News provided by

Cellect Biotechnology Ltd.

May 11, 2020, 02:13 ET